The Canadian Task Force’s 2014 guideline on prostate cancer screening has been criticized for ineffective use of stakeholder input and lack of expert knowledge. The guideline was devoid of a wealth of relevant research data, largely basing its conclusions on two clinical trials. Subsequent critique by a stakeholder panel led by the author led to no modifications in the guideline and the collective resignation of the panel before the guideline’s publication. The field has significantly evolved since, while the guideline remains ignored by many Canadian physicians.
“An Expensive Problem”: Cracking the Cyber Insurance Conundrum
Rampant ransomware attacks have hit the healthcare industry, with incidents increasing by more than 600%, costing an average of $10 million per breach. This has
